Your browser doesn't support javascript.
loading
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Bruce, Ian N; O'Keeffe, Aidan G; Farewell, Vern; Hanly, John G; Manzi, Susan; Su, Li; Gladman, Dafna D; Bae, Sang-Cheol; Sanchez-Guerrero, Jorge; Romero-Diaz, Juanita; Gordon, Caroline; Wallace, Daniel J; Clarke, Ann E; Bernatsky, Sasha; Ginzler, Ellen M; Isenberg, David A; Rahman, Anisur; Merrill, Joan T; Alarcón, Graciela S; Fessler, Barri J; Fortin, Paul R; Petri, Michelle; Steinsson, Kristjan; Dooley, Mary Anne; Khamashta, Munther A; Ramsey-Goldman, Rosalind; Zoma, Asad A; Sturfelt, Gunnar K; Nived, Ola; Aranow, Cynthia; Mackay, Meggan; Ramos-Casals, Manuel; van Vollenhoven, Ronald F; Kalunian, Kenneth C; Ruiz-Irastorza, Guillermo; Lim, Sam; Kamen, Diane L; Peschken, Christine A; Inanc, Murat; Urowitz, Murray B.
Afiliación
  • Bruce IN; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK The Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Uni
  • O'Keeffe AG; Department of Statistical Science, University College London, London, UK.
  • Farewell V; MRC Biostatistics Unit, Cambridge, UK.
  • Hanly JG; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Manzi S; Department of Medicine, West Penn Allegheny Health System, Pittsburgh, Pennsylvania, USA.
  • Su L; MRC Biostatistics Unit, Cambridge, UK.
  • Gladman DD; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
  • Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
  • Sanchez-Guerrero J; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
  • Romero-Diaz J; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico.
  • Gordon C; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Wallace DJ; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Clarke AE; Division of Rheumatology, University of Calgary, Alberta, Canada.
  • Bernatsky S; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Ginzler EM; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA.
  • Isenberg DA; Centre for Rheumatology Research, University College London, London, UK.
  • Rahman A; Centre for Rheumatology Research, University College London, London, UK.
  • Merrill JT; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Alarcón GS; Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Fessler BJ; Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Fortin PR; Division of Rheumatology, Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada.
  • Petri M; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Steinsson K; Center for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland.
  • Dooley MA; Division of Rheumatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Khamashta MA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK.
  • Ramsey-Goldman R; Northwestern University and Feinberg School of Medicine, Chicago, Illinois, USA.
  • Zoma AA; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK.
  • Sturfelt GK; Department of Rheumatology, University Hospital Lund, Lund, Sweden.
  • Nived O; Department of Rheumatology, University Hospital Lund, Lund, Sweden.
  • Aranow C; Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • Mackay M; Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • Ramos-Casals M; Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.
  • van Vollenhoven RF; Unit for Clinical Therapy Research Inflammatory Diseases (ClinTRID), Karolinska Institute, Stockholm, Sweden.
  • Kalunian KC; UCSD School of Medicine, La Jolla, California, USA.
  • Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
  • Lim S; Emory University, Atlanta, Georgia, USA.
  • Kamen DL; Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Peschken CA; University of Manitoba, Winnipeg, Manitoba, Canada.
  • Inanc M; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Urowitz MB; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
Ann Rheum Dis ; 74(9): 1706-13, 2015 Sep.
Article en En | MEDLINE | ID: mdl-24834926
ABSTRACT
BACKGROUND AND

AIMS:

We studied damage accrual and factors determining development and progression of damage in an international cohort of systemic lupus erythematosus (SLE) patients.

METHODS:

The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort recruited patients within 15 months of developing four or more 1997 American College of Rheumatology (ACR) criteria for SLE; the SLICC/ACR damage index (SDI) was measured annually. We assessed relative rates of transition using maximum likelihood estimation in a multistate model. The Kaplan-Meier method estimated the probabilities for time to first increase in SDI score and Cox regression analysis was used to assess mortality.

RESULTS:

We recruited 1722 patients; mean (SD) age 35.0 (13.4) years at cohort entry. Patients with damage at enrolment were more likely to have further worsening of SDI (SDI 0 vs ≥1; p<0.001). Age, USA African race/ethnicity, SLEDAI-2K score, steroid use and hypertension were associated with transition from no damage to damage, and increase(s) in pre-existing damage. Male gender (relative transition rates (95% CI) 1.48 (1.06 to 2.08)) and USA Caucasian race/ethnicity (1.63 (1.08 to 2.47)) were associated with SDI 0 to ≥1 transitions; Asian race/ethnicity patients had lower rates of new damage (0.60 (0.39 to 0.93)). Antimalarial use was associated with lower rates of increases in pre-existing damage (0.63 (0.44 to 0.89)). Damage was associated with future mortality (HR (95% CI) 1.46 (1.18 to 1.81) per SDI point).

CONCLUSIONS:

Damage in SLE predicts future damage accrual and mortality. We identified several potentially modifiable risk factors for damage accrual; an integrated strategy to address these may improve long-term outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Etnicidad / Estado de Salud / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Etnicidad / Estado de Salud / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2015 Tipo del documento: Article
...